baber/WOPTO huggingface dataset:
Patent EP-1409781-A2 (EP)
Inventor: DESAI FRED N
IPC: D04H1/54
Filed: 2002-07-19
Abstract: An extensible apertured nonwoven web, and a method for making such an apertured nonwoven web. In one embodiment the method comprises the steps of providing an apertured nonwoven web, incrementally stretching it in a direction substantially parallel to the cross machine direction, and applying tension in the machine direction such that the web width after applying tension is less than the web width after incremental stretching. In another embodiment the method comprises the steps of providing a nonwoven web; weakening the nonwoven web at a plurality of locations to create a plurality of weakened, melt-stabilized locations; applying a first tensioning force to the nonwoven web to cause the nonwoven web to rupture at the plurality of weakened, melt-stabilized locations creating a plurality of apertures in the nonwoven web coincident with the weakened, melt-stabilized locations, incrementally stretching the nonwoven web in a direction substantially parallel to the cross machine direction, and applying tension in the machine direction such that the web width after applying machine direction tension is less than the web width after incremental stretching. An apparatus for producing a web of the present invention by this method is also disclosed. The extensible apertured nonwoven web produced has a plurality of apertures each having a hole size greater than 2 mm2, and a hole aspect ratio less than 6, the nonwoven web having an open area greater than 15% and being capable of at least 70% extension in the cross machine direction at a loading of 10 g/cm.
Patent EP-1451315-A2 (EP)
Title: Polypeptides du facteur vii de coagulation humain
Inventor: PERSSON EGON
IPC: C12P21/02
Filed: 2002-11-01
Abstract: La présente invention concerne de nouvelles variantes du facteur VII de coagulation humain ayant une activité de coagulation ainsi que des structures de polynucléotides codant ces variantes, des vecteurs et des cellules hôtes comprenant et exprimant le polynucléotide, des compositions pharmaceutiques, des applications et des procédés de traitement.
Patent EP-1438578-A2 (EP)
Inventor: WOLFE THOMAS D
IPC: B01D61/22
Filed: 2002-10-18
Abstract: L'invention concerne un procédé permettant de surveiller les paramètres de fonctionnement quotidien de processus de traitement de l'eau au moyen d'une collecte de données localisées. Ces données sont manipulées pour générer un fonctionnement, un entretien et des rapports de contrôle de la qualité préconfigurés et pour soumettre automatiquement des données selon les besoins pour un examen réglementaire de certains systèmes de traitement de l'eau, tels que le traitement de l'eau potable. Les données sont collectées par des capteurs situés dans un site d'équipement et transférées dans un emplacement éloigné localisé par Internet et toutes les autres données reçues et utilisées pour générer des rapports sont également accessibles par Internet et sont délivrées directement à l'agence de régulation sans passer par un processus supplémentaire.
Patent EP-1446676-A2 (EP)
Title: Systeme d'imagerie electronique a matrice en grille de points
Inventor: ALMOGY GILAD
IPC: H01J37/28
Filed: 2002-11-07
Abstract: L'invention concerne un système d'imagerie à matrice en grille de points à faisceau d'électrons, à haut débit binaire, permettant de résoudre les problèmes de faible résolution et les exigences de linéarité stricte des systèmes antérieurs. Des modes de réalisation comprennent un système d'imagerie comportant un générateur de faisceaux d'électrons destiné à irradier simultanément une matrice de points espacés les uns des autres sur la surface d'un objet à imager, ainsi qu'un détecteur destiné à recueillir des électrons rétrodiffusés et/ou secondaires émis suite à l'interaction des points avec la surface de l'objet, de sorte à former une image des parties irradiées de la surface de l'objet. Un système mécanique déplace le substrat dans une direction pratiquement parallèle à un axe de la matrice de points, de sorte que, à mesure que le substrat se déplace à travers la matrice de points dans le sens du balayage (direction y), les points tracent un trajet qui ne laisse pas d'écart dans le sens du balayage transversal mécanique (direction x). Un compensateur, tel qu'un servo ou un miroir mobile, compense les imprécisions mécaniques de l'étape de déplacement, ce qui permet d'améliorer la précision de l'imagerie. Dans d'autres modes de réalisation, des détecteurs multiples placés selon des angles différents par rapport au substrat recueillent des électrons pour fournir une imagerie à perspectives multiples de la surface du substrat.
Patent EP-1329323-A2 (EP)
Inventor: LOUIE ANGELA
IPC: B41J2/175
Filed: 2003-01-16
Abstract: The method for producing an ink container involves introduction of one or more porous ink absorption elements into a container with at least one ink chamber. The total volume of the elements, being in dry state less than the volume of the container, increases when these elements come into contact with the ink.  An Independent claim is also included for a resultant ink container.
Patent EP-1380861-A2 (EP)
Inventor: SIGALAS MIHAIL M
IPC: G02B6/12
Filed: 2003-04-09
Abstract: A two-dimensional photonic crystal slab apparatus having a waveguiding
capability is provided. Noncircular holes are introduced to replace the circular holes
in the two-dimensional lattice of the photonic crystal to provide waveguiding
capability. High guiding efficiency is achieved over a wide frequency region within
the photonic bandgap.
Patent EP-1367708-A2 (EP)
Inventor: MATSUI KEIZO
IPC: H02P6/18
Filed: 2003-05-27
Abstract: A motor driving apparatus includes current
detecting means (7a, 7b) for detecting a current flowing in
a motor (4), current control means (12) for controlling the
current flowing in the motor (4) to a predetermined value
with reference to the detected current, and current control
gain adjusting means (16) for changing a control gain in
the current control means (12) according to an amplitude of
the current flowing in the motor (4).
Patent EP-1384895-A2 (EP)
Inventor: LOHSE WALTER
IPC: F04D9/00
Filed: 2003-06-28
Abstract: The pump (1) is located in a sump pump and fastened by a holder (4) to an elbow pipe (7). The holder has an upward extending ventilation pipe (9), which has a back pressure element (10,12) to prevent entry of fluid from the pump sump into the pump. The holder also has an upward facing bore containing a floating conical closure part (10), which acts sealing with a seat formed by a constriction in the bore. A pipe connected to the bore merges into an elbow (11) with downward direction opening closed by a floating closure part (12). This is formed by a flap, fastened moveable to the elbow.
Patent EP-1366771-A2 (EP)
Inventor: AOKI K ROGER
IPC: A61K38/48
Filed: 1994-12-16
Abstract: The present invention relates to neurotoxic components of
Botulinum toxin for use as a medicament.
Patent EP-1433958-A2 (EP)
Inventor: BAUERLE MICHAEL
IPC: F04D29/42
Filed: 2003-07-24
Abstract: The inlet stator (12) has several inlet guide vanes (16) in the flow incidence region of a compressor wheel whose spin-generating vane angle can be varied depending on a fluid volumetric flow through the flow machine or turbo-compressor. The inlet guide vanes undergo variable deformation under varying flow conditions. The inlet guide vanes are made of a deformable material and are flexible.
Patent EP-1413402-A2 (EP)
Inventor: DROSTE MANFRED DIPL-ING
IPC: B23B45/16
Filed: 2003-10-20
Abstract: A hand-held powered hammer comprising a hammer housing (2), a spindle (4) rotatably mounted within the housing, a hammering mechanism (24, 28, 32) for generating repeated impacts on a tool or bit mounted at the forward end of the spindle, a spindle lock arrangement (60), comprising at least one spindle lock tooth (66), which arrangement is mounted within the housing and a set of teeth (43) arranged for rotation with the spindle. The hammer, which may be a rotary hammer, has at least two modes including a first mode, which may be a rotary hammer or drilling only mode, in which the spindle is rotatable within the housing and a second mode, which may be a hammer only mode, in which the set of teeth (43) engage the spindle lock tooth or teeth (66) so as to lock the spindle (4) against rotation within the housing. An improved spindle lock arrangement (60) is provided which comprises a resilient synchronising element (72, 74, 92) positioned to engage the set of teeth before the spindle lock tooth or teeth engage the set of teeth on movement from the first mode to the second mode so as to bring the set of teeth into meshing alignment with spindle lock tooth or teeth.
Patent EP-1429280-A2 (EP)
Inventor: BOOSE MOLY L
IPC: G06T7/60
Filed: 2003-11-27
Abstract: Apparatus and methods for converting raster illustrated parts images
into intelligent vector-layered files. The method involves recognizing and
removing reference labels from the raster illustrated parts image to produce a
reference label scrubbed file. Reference lines are recognized and removed
from the reference label scrubbed file to produce a scrubbed file. The
scrubbed file includes a reusable base graphic. The scrubbed file is converted
to a vector file in which the reusable base graphic is embedded. One or more
vector layers are added to the vector file to produce the intelligent vector-layered
file. Each vector layer includes vector elements corresponding to one
of the recognized reference labels and its one or more reference lines.
Patent EP-1403689-A2 (EP)
Inventor: LOWERY CHRISTOPHER H
IPC: H01L33/32
Filed: 2003-09-17
Abstract: A backlight for an LCD uses as a light source at least one red light source, at lest one green light source, at least one blue light source, wherein one of the sources comprises a light emitting diode capable of emitting light at a first wavelength and a wavelength-converting material capable of absorbing light of the first wavelength and emitting light of a second wavelenght. In some embodiments, the wavelength-converting material is a strontium thiogallate phosphor or a nitridosilicate phosphor. In some embodiments, the first wavelength is about the same as light emitted by the blue light source, or is barely visible to the human eye.
Patent EP-1359603-A2 (EP)
Inventor: VAN DE GOOR TOM A
IPC: H01J49/04
Filed: 2003-04-29
Abstract: The invention relates to a device  (10)  for transporting sample fluids into a mass
spectrometer. The device  (10)  comprises a well plate  (20)  comprising a plurality of wells
 (24, 26),  a fluid transporting assembly  (40),  and a mass spectrometer interface  (80).  The
fluid-transporting assembly  (40)  is comprised of a plurality of fluid-transporting conduits  (66,
68),  each extending from an inlet port  (66A, 68A)  to an outlet port  (66B, 68B),  wherein the
assembly exhibits sufficient flexibility to allow movable positioning of the outlet ports  (66B,
68B)  with respect to the inlet ports  (66A, 68A).  Each inlet port  (66A, 68A)  of the fluid-transporting
assembly  (40)  is positioned in fluid communication with a different well  (24, 26) 
of the well plate  (20)  to form a plurality of flow paths. Each flow path originates at a well
and travels, in succession, through the conduit inlet port, the conduit, the conduit outlet port,
and the mass spectrometer interface. Fluids emerging from the mass spectrometer interface
 (80)  may be introduced into a mass spectrometer. The invention also provides a method for
transporting sample fluids into a mass spectrometer.
Patent EP-1387240-A2 (EP)
Inventor: TANAKA WATARU
IPC: G09F9/00
Filed: 2003-07-04
Abstract: A display device is disclosed comprising a housing (5,
6), a plate-shaped display unit (4) having respective side
walls, and a fixing means (11) for fixing the display unit
to the housing. The fixing means includes a Z-direction
holding means for holding the display unit in the thickness
direction and also includes an X-direction holding means
and a Y-direction holding means for holding the display
unit in the X-direction and the Y-direction perpendicular
to the X-direction. At least one of the X-direction
holding means and the Y-direction holding means is composed
of wall sections, which are opposed to each other, of the
housing adjacent to respective side walls of the display
unit. A protruding section is formed which protrudes from
the side wall of the display unit to the wall section, the
wall section having a cutout engaging with the protruding
section at a position of the wall section corresponding to
the protruding section. The other of the X-direction
holding means and the Y-direction holding means is composed
by engagement of the protruding section with the cutout.
Patent EP-1403466-A2 (EP)
Inventor: NGUYEN PHILIP D
IPC: E21B43/267
Filed: 2003-07-04
Abstract: Proppant particles coated with a tacky resin coating are suspended in a gelled liquid fracturing fluid and conveyed into formations where the resin hardens to weakly consolidate the proppant particles so that fines will stick to the proppant packs.
Patent EP-1492761-A2 (EP)
Title: Acides amines a affinite vis-a-vis de la proteine alpha-2-delta
Inventor: BARTA NANCY SUE
IPC: A61P21/00
Filed: 2003-03-17
Abstract: L'invention concerne certains bêta-aminoacides qui se lient avec la sous-unité α2δ d'un canal calcique. Ces composés et leurs sels pharmaceutiquement acceptables sont utiles pour le traitement d'un éventail de troubles psychiatriques, de la douleur, et autres affections.
Patent EP-1507555-A2 (EP)
Title: Induction de la tolerance immunologique specifique d'antigenes
Inventor: KAKKIS EMIL D
IPC: A61K38/095
Filed: 2003-05-05
Abstract: Selon la présente invention, une tolérance immunitaire spécifique d'antigènes est induite chez un hôte mammalien par administration d'un tolérogène en combinaison avec un régime d'immunosuppression. Ces méthodes comprennent facultativement une période de conditionnement antérieure, au cours de laquelle des agents immunosuppresseurs sont administrés en l'absence du tolérogène. Après le régime de tolérance, l'hôte est retiré des agents suppresseurs, mais il est capable de maintenir une tolérance immunitaire spécifique vis-à-vis des épitopes immunogéniques présents sur le tolérogène. De façon optimale, le tolérogène présente des propriétés de reprise élevée qui lui permettent de reprendre in vivo à des concentrations basses dans une grande variété de types cellulaires de tolérance.
Patent EP-1501534-A2 (EP)
Inventor: NILSSON ANDERS
IPC: A61K38/095
Filed: 2003-05-07
Abstract: On peut obtenir de la desmopressine présentant une bonne biodisponibilité au moyen d'une forme posologique pouvant se disperser dans la bouche. Les formes posologiques préférées comportent de la desmopressine et un réseau matriciel ouvert du type support hydrosoluble inerte ou pouvant se disperser dans l'eau.  La desmopressine ainsi formulée peut servir à retarder la miction ou à traiter ou prévenir l'incontinence, l'énurésie nocturne primaire, la nycturie ou le diabète insipide d'origine centrale. On peut également formuler de cette manière des peptides autres que la desmopressine.
Patent EP-1487274-A2 (EP)
Inventor: NIKLASON LAURA E
IPC: A61K35/12
Filed: 2003-03-17
Abstract: The present invention relates, in general, to tissue engineering and, in particular, to a method of extending the lifespan of cells suitable for use in vascular engineering.
Patent EP-1470457-A2 (EP)
Inventor: AHMED OSMAN
IPC: G05B15/02
Filed: 2003-01-28
Abstract: A procedure is enabled to respond to an order en route to a marketplace so that the procedure can determine whether to generate a spawned order, and the spawned order is sent to a destination for execution essentially contemporaneously with the sending of the en route order to the marketplace. The spawned order can be sent to the same marketplace or a different marketplace than the en route order is sent to. The spawned orders provide additional liquidity.
Patent EP-1516295-A2 (EP)
Inventor: DEMMELER ERWIN
IPC: G07D11/00
Filed: 2003-06-11
Abstract: The present invention relates to an apparatus and method for processing bank notes present as separate deposits. To improve the processing reliability of the individual deposits, it is provided that the beginning and/or end of each deposit is recognized, and a separate carrier is used for each deposit for transporting the deposit to processing.
Patent EP-1519685-A2 (EP)
Inventor: SHERMAN MICHAEL C
IPC: A61B17/02
Filed: 2003-06-17
Abstract: A minimaly invasive spacer for positioning between vertebral members. The spacer is adjustable between a first orientation having a reduced size to facilitate insertion between the vertebral members. A second orientation has an enlarged size for contacting the vertebral members. The spacer includes linkages that are attached to a pair of plates. A pull arm is operatively connected to the linkages for adjusting the spacer from the first orientation to the second orientation. A delivery device is attached to the spacer for insertion between the vertebral members. In one embodiment, the delivery device is detachable to be removed from the spacer once positioned between the vertebral members. Methods of using the spacer include positioning the spacer between the vertebral members while in the first orientation. The spacer is then enlarged to the second orientation, and the delivery device is removed with only the spacer remaining within the patient.
Patent EP-1493178-A2 (EP)
Inventor: BAKKERS ERIK P A M
IPC: H01L21/3065
Filed: 2003-03-26
Abstract: In the method, semiconductor substrates are etched to provide nanowires, said substrates comprising a first layer of a first material and a second layer of a second material with a mutual interface, which first and second materials are different. They may be different in the doping type. Alternatively, the main constituent of the material may be different, for example SiGe or SiC versus Si, or InP versus InAs. In the resulting nanowires, the interface is atomically sharp. The electronic devices having nanowires between a first and second electrode accordingly have very good electroluminescent and optoelectronic properties.
Patent EP-1490104-A2 (EP)
Title: Vaccins contre streptococcus pneumoniae a base proteique
Inventor: MIZRACHI NEBENZAHL YAFFA
IPC: A61K39/09
Filed: 2003-04-01
Abstract: La présente invention concerne un procédé de prévention d'une infection par S. pneumoniae chez un mammifère. Ledit procédé consiste à administrer audit mammifère une quantité efficace d'une ou plusieurs protéines pariétales et/ou membranaires de cellules S. pneumoniae, lesdites protéines étant choisies dans un groupe défini de protéines immunogènes. La présente invention concerne également des compositions de vaccin contenant lesdites protéines pariétales et/ou membranaires de cellules.
Patent EP-1543501-A2 (EP)
Inventor: JUNQUA JEAN-CLAUDE
IPC: G10L13/02
Filed: 2003-09-10
Abstract: Un utilisateur personnalise une voix synthétisée dans un système réparti de synthèse de la parole. L'utilisateur sélectionne des critères de voix au niveau d'un dispositif local. Ces critères de voix représentent des caractéristiques que l'utilisateur souhaite pour une voix synthétisée. Lesdits critères de voix sont communiqués à un dispositif de réseau. Ce dispositif de réseau génère un ensemble de règles relatives à la voix synthétisée et basées sur les critères de voix. Ces règles relatives à la voix synthétisée représentent des aspects prosodiques ainsi que d'autres caractéristiques de la voix synthétisée. Les règles de voix synthétisée sont communiquées au dispositif local et utilisées pour créer la voix synthétisée.
Patent EP-1572269-A2 (EP)
Inventor: PARKER DAVID WILLIAM
IPC: A61M5/32
Filed: 2003-10-01
Abstract: A hypodermic syringe comprises a housing ( 1 ), which includes a barrel portion ( 1.4 ) and an injectant chamber ( 1.5 ), where the injectant chamber has a smaller cross-sectional area than the barrel portion ( 1.4 ). A plunger ( 2 ), which comprises a piston ( 3 ), is slideably mounted within the barrel portion ( 1.4 ) and extends into the injectant chamber ( 1.5 ). A retractable needle assembly ( 5 ) is provided, together with stored energy means ( 4 ), so that, at the completion of an injection stroke, the piston ( 3 ) becomes attached to the needle assembly ( 5 ) and the stored energy is released to retract the needle assembly ( 5 ) into the housing ( 1 ). Co-operating features ( 3.7, 5.7 ) may be arranged on the piston ( 3 ) and needle assembly ( 5 ) so that complete evacuation of the injectant chamber ( 1.5 ) is not impeded. As the parameters of the stored energy means ( 4 ) are not limited by the physical dimensions of the injectant chamber ( 1.5 ), this arrangement is particularly suitable for small capacity syringes, i.e. 3 ml or less.
Patent EP-1551637-A2 (EP)
Title: Dispositif d'ejection de gouttelettes
Inventor: HASENBEIN ROBERT A
IPC: B41J2/14
Filed: 2003-09-30
Abstract: La présente invention concerne un dispositif d'éjection de gouttelettes. Ledit dispositif comprend un corps définissant une pluralité de chemins de fluides qui comprennent chacun une entrée présentant un dispositif d'étranglement d'écoulement, une chambre de pompage et une ouverture de buse communiquant avec la chambre de pompage permettant l'évacuation des gouttelettes de fluide. Un actionneur est associé à chaque chambre de pompage. La chambre de pompage présente une dimension plus importante qui est suffisamment courte et le dispositif d'étranglement de débit assure une résistance à l'écoulement suffisante pour assurer une vitesse aux gouttelettes de fluide et/ou une réponse de volume/fréquence qui varie de moins plus ou moins 25 % sur une bande de fréquences de gouttelettes comprise entre 0 et 40 kHz. L'invention concerne également des dispositifs d'éjection de gouttelettes de fluides dans lesquels le rapport de la résistance à l'écoulement d'entrée par rapport à l'impédance de l'écoulement de la chambre de pompage est comprise entre 0,05 et 0,9, la chambre de pompage présentant une constante de temps pour l'affaiblissement d'une onde de pression dans la chambre de pompage qui est inférieure à 25 microsecondes.
Patent EP-1579481-A2 (EP)
Inventor: HORSKY THOMAS N
IPC: H01L21/336
Filed: 2003-06-26
Abstract: An ion implantation device and a method of manufacturing a semiconductor device is described, wherein ionized boron hydride molecular clusters are implanted to form P-type transistor structures. For example, in the fabrication of Complementary Metal-Oxide Semiconductor (CMOS) devices, the clusters are implanted to provide P-type doping for Source and Drain structures and for Polygates; these doping steps are critical to the formation of PMOS transistors. The molecular cluster ions have the chemical form BnHx+ and BnHx-, where 10<n<100 and 0≤x≤n+4. The use of such boron hydride clusters results in a dramatic increase in wafer throughput, as well as improved device yields through the reduction of wafer charging. Thus, this technology significantly reduces manufacturing costs relative to prior implantation techniques. A method of manufacturing a semiconductor device is further described, comprising the steps of: providing a supply of molecules containing a plurality of dopant atoms into an ionization chamber, ionizing said molecules into dopant cluster ions, extracting and accelerating the dopant cluster ions with an electric field, selecting the desired cluster ions by mass analysis, modifying the final implant energy of the cluster ion through post-analysis ion optics, and implanting the dopant cluster ions into a semiconductor substrate. In general, dopant molecules contain n dopant atoms, where n is an integer number greater than 10. This method enables increasing the dopant dose rate to n times the implantation current with an equivalent per dopant atom energy of 1/n times the cluster implantation energy, while reducing the charge per dopant atom by the factor n. This is an effective method for making shallow transistor junctions, where it is desired to implant with a low energy per dopant atom.